China’s dissemination of health care insurance throughout the country will power 20% annual growth in spending for medicines in the country, according to Liam Condon, who spearheaded Bayer AG’s operations in China until the end of 2009. Bayer itself expects to produce returns that beat the 20% rate of growth. “There’s a lot of demand [in China] that’s not being tapped at the moment,” commented Condon. More details...

Stock Symbol: (XETRA: BAY)